These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19527736)

  • 1. Deleterious effects of silymarin on the expression of genes controlling endothelial nitric oxide synthase activity in carbon tetrachloride-treated rat livers.
    Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Jin W; Kwon YH; Shin MK; Yoo TM; Kang JH; Park CS
    Life Sci; 2009 Aug; 85(7-8):281-90. PubMed ID: 19527736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The anti-portal hypertension effect of oleanolic acid in CCl4-induced cirrhosis rats].
    Liu CH; Huang XT; Li YY; Zheng X; Li N; Mi SQ; Wang NS
    Zhong Yao Cai; 2012 Jun; 35(6):930-5. PubMed ID: 23236829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid.
    Muriel P; Moreno MG; Hernández Mdel C; Chávez E; Alcantar LK
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):375-80. PubMed ID: 15853930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
    Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
    Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.
    Matei V; Rodríguez-Vilarrupla A; Deulofeu R; Colomer D; Fernández M; Bosch J; Garcia-Pagán JC
    Hepatology; 2006 Jul; 44(1):44-52. PubMed ID: 16799985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The roles of caveolin-1 and endothelial nitric oxide synthase in the development of portal hypertension in rats with liver cirrhosis].
    Xu B; Zhu GH; Weng JF; Cai WS; Xia JT; Li SH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):184-7. PubMed ID: 18364076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats.
    Favari L; Pérez-Alvarez V
    Arch Med Res; 1997; 28(1):11-7. PubMed ID: 9078581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats.
    Malyshev E; Tazi KA; Moreau R; Lebrec D
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2195-201. PubMed ID: 18031380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.
    Abraldes JG; Rodríguez-Vilarrupla A; Graupera M; Zafra C; García-Calderó H; García-Pagán JC; Bosch J
    J Hepatol; 2007 Jun; 46(6):1040-6. PubMed ID: 17335931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis.
    Yamaguchi S; Kawanaka H; Yoshida D; Maehara Y; Hashizume M
    Life Sci; 2007 May; 80(22):2036-44. PubMed ID: 17481668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranslational activation of endothelial nitric oxide synthase attenuates carbon tetrachloride-induced hepatotoxicity in newborn rats.
    Liu H; Subramony C; Nowicki M
    Pediatr Res; 2008 Jun; 63(6):613-9. PubMed ID: 18317400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Akt gene therapy for cirrhotic rats with portal hypertension].
    Huang FZ; Deng G; Liu XY; Luo CQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
    Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats].
    Zhao XY; Wang BE; Wang TL; Li XM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2563-6. PubMed ID: 17198567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effects of Hibiscus sabdariffa extract on CCl4-induced liver fibrosis in rats.
    Liu JY; Chen CC; Wang WH; Hsu JD; Yang MY; Wang CJ
    Food Chem Toxicol; 2006 Mar; 44(3):336-43. PubMed ID: 16176854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
    Yao HW; Li J; Chen JQ; Xu SY
    Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPS inhibits endothelin-1-induced endothelial NOS activation in hepatic sinusoidal cells through a negative feedback involving caveolin-1.
    Kamoun WS; Karaa A; Kresge N; Merkel SM; Korneszczuk K; Clemens MG
    Hepatology; 2006 Jan; 43(1):182-90. PubMed ID: 16374854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trolox down-regulates transforming growth factor-beta and prevents experimental cirrhosis.
    Galicia-Moreno M; Rodríguez-Rivera A; Reyes-Gordillo K; Segovia J; Shibayama M; Tsutsumi V; Vergara P; Moreno MG; Fernández-Martínez E; Pérez-Alvarez VM; Muriel P
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):476-81. PubMed ID: 18811677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.